Grace Therapeutics, Inc. (GRCE): auditor change — Acasti Pharma dismisses KPMG as auditor, appoints Ernst & Young

Grace Therapeutics, Inc.

Audit committee and board approved dismissal of KPMG on February 22, 2023.
KPMG's reports for fiscal years ended March 31, 2022 and 2021 were unqualified with no adverse opinions.
No disagreements or reportable events occurred between the company and KPMG during the relevant periods.
Board approved engagement of Ernst & Young LLP as new independent auditor for fiscal year ending March 31, 2023.
KPMG furnished a letter to the SEC agreeing with the company's disclosures.

item 4.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

Grace Therapeutics, Inc. engaged Ernst & Young LLP as its auditor.

Action: engagement
Auditor: Ernst & Young LLP

Exact text from the filing

On February 22, 2023, in connection with the Company’s dismissal of KPMG, the Board approved the engagement of Ernst & Young LLP (“E&Y”) as its new independent registered public accounting firm to audit the Company’s financial statements for the fiscal year ending March 31, 2023.

View on SEC.gov

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

Grace Therapeutics, Inc. dismissed KPMG LLP as its auditor.

Action: dismissal
Auditor: KPMG LLP
Successor: Ernst & Young LLP

Exact text from the filing

On February 22, 2023, the audit committee and board of directors (the “Board”) of the Company approved the dismissal of KPMG as the Company’s independent registered public accounting firm.

View on SEC.gov

Browse all auditor changes →

Grace Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0000950170-23-003847

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.